Discover published sets by community

Prostate Cancer; PSA is used to screen for and monitor prostate cancer.

Breast Cancer; PR status is used to understand hormone sensitivity in breast cancer.

Pancreatic Cancer; CA 19-9 can be used to monitor treatment progress and disease recurrence.

Colorectal Cancer; KRAS mutations influence response to certain cancer therapies.

Breast Cancer; HER2 is an important prognostic and predictive marker.

Liver Cancer; DCP is an abnormal prothrombin associated with hepatocellular carcinoma.

Gestational Trophoblastic Disease; hCG is a marker used in diagnosing and monitoring treatment.

Breast Cancer; ER status can dictate hormone therapy in breast cancer treatment.

Multiple Myeloma; Abnormally high or low levels of immunoglobulins can indicate multiple myeloma or other conditions.

Lung Cancer; ALK rearrangements are important for targeted therapy decision.

Thyroid Cancer; Used to detect and monitor the recurrence of thyroid cancer.

Bladder Cancer; NMP22 is a marker to diagnose and monitor bladder cancer.

Bladder Cancer; UroVysion uses fluorescence in situ hybridization to detect bladder cancer cells.

Melanoma; S-100 is a protein marker used in diagnosing and monitoring melanoma.

Multiple Myeloma; B2M can be used to prognosis and monitor treatment effects.

Ovarian Cancer; CA-125 can indicate the presence of ovarian cancer, especially in postmenopausal women.

Melanoma; BRAF mutations are significant for targeted therapy in melanoma.

Non-Hodgkin Lymphoma; CD20 is a marker used to identify and treat certain lymphomas.

Breast Cancer; CA-27.29 can monitor treatment and recurrence in breast cancer.

Liver Cancer; AFP is a marker for hepatocellular carcinoma and testicular cancer.

Chronic Myeloid Leukemia; BCR-ABL is a genetic marker for this leukemia type.

Lung Cancer; Mutations in EGFR are critical for selecting targeted therapies.

Small Cell Lung Cancer; ProGRP can help distinguish SCLC from other lung cancers.

Gastrointestinal Stromal Tumors; CD117 is a marker that suggests the presence of GISTs.

Breast Cancer; CA 15-3 can be used to monitor the course of disease in breast cancer patients.

Many Cancers; LDH levels can indicate tissue damage and tumor burden.

Breast and Pancreatic Cancer; MUC1 is a mucin protein elevated in certain adenocarcinomas.

Colorectal Cancer; CEA is used to monitor treatment and recurrence in colorectal cancer.

Hodgkin Lymphoma; CD30 is a marker found on Reed-Sternberg cells characteristic of Hodgkin lymphoma.